Nuclear Medicine Equipment Market was value US$ 2.83 Bn in 2023 and is expected to reach US$ 3.69 Bn by 2030 at a CAGR of 3.87%. Nuclear medicine equipment utilizes radioactive compounds (also known as nuclear medicine or radiopharmaceuticals) that are either orally or intravenously injected into the body. These devices use radiopharmaceutical radiation to generate pictures of the structures and activities inside the human body. These pictures allow doctors to see into a person's body to diagnose the origin of a disease or injury and deliver an accurate diagnosis.To know about the Research Methodology:- Request Free Sample Report Rising cancer prevalence, cardiovascular complications, and neurodegenerative problems; growing awareness about the importance of early disease diagnosis; the introduction of advanced nuclear medicine equipment into the market; and the increasing adoption of nuclear medicine appliances by end users are major factors driving the market growth. However, the high cost of nuclear medicine equipment and radiopharmaceutical half-life is estimated to limit the market growth. Also, the increased usage of repurposed diagnostic imaging systems, as well as hospital budget constraints, pose a challenge to the industry growth. On the other hand, the market is likely to benefit from a solid product pipeline as well as growth and penetration prospects in emerging markets. Some of the leading key players in the global Nuclear Medicine Equipment Market include Philips Healthcare, GE Healthcare, and Cardinal Health Inc. They are continuously strategizing on mergers and acquisitions, strategic alliances, joint ventures, and partnerships for the growth of their market shares. The Nuclear medicine equipment is designed to solve the diagnostic challenges, a medical image using a small amount of radioactive material to diagnose and control the severity of or for treating numerous disease for instance cancer, heart diseases, neurological disorders, and other abnormalities within the body. The increasing prevalence of disease among the geriatric population, durable product pipeline, and a growing demand for nuclear medicine procedures in the emerging market are expected to fuel market growth in the forecast years. The high cost of nuclear medicine equipment’s and reduced half-life radiopharmaceuticals hamper the growth of the nuclear medicine equipment market globally. Furthermore, lack of effective data & evidence that supports nuclear medicines improves the patient’s outcome, less reimbursement of medical imaging, and lack of trained physician and radiologist can restraint growth of global nuclear medicine equipment market. Positron Emission Tomography (PET) dominated the industry in 2023 caused by high-resolution images provided by PET technology that is majorly used in oncology cases to obtain enhanced information about a tumour. Positron Emission Tomography (PET) is sub-segmented into standalone and hybrid. Cost-effectiveness of SPECT will significantly drive segment growth during the forecast period. Cardiology application segment is expected to witness considerable growth over the coming years owing to increasing awareness about cardiac disorders, increasing the number of people suffering from cardiovascular diseases and rising adoption of a sedentary lifestyle and unhealthy diet escalating disease burden. Region-wise, the Asia Pacific is anticipated to register the highest CAGR of 10.5% over the forecast period. Demand for nuclear medicine is growing in emerging markets such as China and India due to increasing disposable income, improving healthcare standards, and favourable reforms in foreign policies. China is dominating the Asia Pacific market and is likely to hold on to its leadership position through 2030.
Market Scope: Inquire before buying
Nuclear Medicine Equipment Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 2.83 Bn. Forecast Period 2024 to 2030 CAGR: 3.87% Market Size in 2030: US $ 3.69 Bn. Segments Covered: by Product Single-Photon Emission Computed Tomography (SPECT) Positron Emission Tomography (PET) by Application Neurology Oncology Cardiology Others by End User Hospitals Imaging Centres Academic & Research Institutes Nuclear Medicine Equipment Maret, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Key Players are:
1. Philips Healthcare 2. GE Healthcare 3. Cardinal Health Inc. 4. Siemens AG 5. Digirad Corporation 6. Mediso Medical Imaging Systems, Ltd. 7. Toshiba Medical Systems Corporation 8. DDD-Diagnostics A/S 9. Neusoft Medical Systems Co. Ltd. 10. Mallinckrodt plc 11. SurgicEye GmbH 12. CMR Naviscan Corporation 13. CANON MEDICAL SYSTEMS CORPORATION 14. DIGIRAD CORPORATION 15. FUJIFILM Holdings Corporation 16. Bozlu Holding 17. Compañía Mexicana de Radiología CRG 18. Bartec Technologies Ltd. 19. Biodex 20. Cyclopharm 21. Standard Imaging Inc.Frequently Asked Questions:
1. Which region has the largest share in Global Nuclear Medicine Equipment Market ? Ans: Asia Pacific region held the highest share in 2023. 2. What is the growth rate of Global Nuclear Medicine Equipment Market t? Ans: The Global Market is growing at a CAGR of 3.87% during forecasting period 2024-2030. 3. What is scope of the Global Nuclear Medicine Equipment Market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this Market? Ans: The Global Market is studied from 2023 to 2030.
Global Nuclear Medicine Equipment Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Nuclear Medicine Equipment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Nuclear Medicine Equipment Market Analysis and Forecast 6.1. Global Nuclear Medicine Equipment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Nuclear Medicine Equipment Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Nuclear Medicine Equipment Market Value Share Analysis, by Product 7.4. Global Nuclear Medicine Equipment Market Size (US$ Bn) Forecast, by Product 7.5. Global Nuclear Medicine Equipment Market Analysis, by Product 7.6. Global Nuclear Medicine Equipment Market Attractiveness Analysis, by Product 8. Global Nuclear Medicine Equipment Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Nuclear Medicine Equipment Market Value Share Analysis, by Application 8.4. Global Nuclear Medicine Equipment Market Size (US$ Bn) Forecast, by Application 8.5. Global Nuclear Medicine Equipment Market Analysis, by Application 8.6. Global Nuclear Medicine Equipment Market Attractiveness Analysis, by Application 9. Global Nuclear Medicine Equipment Market Analysis and Forecast, by End user 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Nuclear Medicine Equipment Market Value Share Analysis, by End user 9.4. Global Nuclear Medicine Equipment Market Size (US$ Bn) Forecast, by End user 9.5. Global Nuclear Medicine Equipment Market Analysis, by End user 9.6. Global Nuclear Medicine Equipment Market Attractiveness Analysis, by End user 10. Global Nuclear Medicine Equipment Market Analysis, by Region 10.1. Global Nuclear Medicine Equipment Market Value Share Analysis, by Region 10.2. Global Nuclear Medicine Equipment Market Size (US$ Bn) Forecast, by Region 10.3. Global Nuclear Medicine Equipment Market Attractiveness Analysis, by Region 11. North America Nuclear Medicine Equipment Market Analysis 11.1. Key Findings 11.2. North America Nuclear Medicine Equipment Market Overview 11.3. North America Nuclear Medicine Equipment Market Value Share Analysis, by Product 11.4. North America Nuclear Medicine Equipment Market Forecast, by Product 11.4.1. Single-Photon Emission Computed Tomography (SPECT) 11.4.1.1. Standalone 11.4.1.2. Hybrid 11.4.2. Positron Emission Tomography (PET) 11.4.2.1. Standalone 11.4.2.2. Hybrid 11.5. North America Nuclear Medicine Equipment Market Value Share Analysis, by Application 11.6. North America Nuclear Medicine Equipment Market Forecast, by Application 11.6.1. Neurology 11.6.2. Oncology 11.6.3. Cardiology 11.6.4. Others 11.7. North America Nuclear Medicine Equipment Market Value Share Analysis, by End user 11.8. North America Nuclear Medicine Equipment Market Forecast, by End user 11.8.1. Hospitals 11.8.2. Imaging Centers 11.8.3. Academic & Research Institutes 11.9. North America Nuclear Medicine Equipment Market Value Share Analysis, by Country 11.10. North America Nuclear Medicine Equipment Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Nuclear Medicine Equipment Market Analysis, by Country 11.12. U.S. Nuclear Medicine Equipment Market Forecast, by Product 11.12.1. Single-Photon Emission Computed Tomography (SPECT) 11.12.1.1. Standalone 11.12.1.2. Hybrid 11.12.2. Positron Emission Tomography (PET) 11.12.2.1. Standalone 11.12.2.2. Hybrid 11.13. U.S. Nuclear Medicine Equipment Market Forecast, by Application 11.13.1. Neurology 11.13.2. Oncology 11.13.3. Cardiology 11.13.4. Others 11.14. U.S. Nuclear Medicine Equipment Market Forecast, by End user 11.14.1. Hospitals 11.14.2. Imaging Centers 11.14.3. Academic & Research Institutes 11.15. Canada Nuclear Medicine Equipment Market Forecast, by Product 11.15.1. Single-Photon Emission Computed Tomography (SPECT) 11.15.1.1. Standalone 11.15.1.2. Hybrid 11.15.2. Positron Emission Tomography (PET) 11.15.2.1. Standalone 11.15.2.2. Hybrid 11.16. Steel Canada Nuclear Medicine Equipment Market Forecast, by Application 11.16.1. Neurology 11.16.2. Oncology 11.16.3. Cardiology 11.16.4. Others 11.17. Canada Nuclear Medicine Equipment Market Forecast, by End user 11.17.1. Hospitals 11.17.2. Imaging Centers 11.17.3. Academic & Research Institutes 11.18. North America Nuclear Medicine Equipment Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By Application 11.18.3. By End user 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Nuclear Medicine Equipment Market Analysis 12.1. Key Findings 12.2. Europe Nuclear Medicine Equipment Market Overview 12.3. Europe Nuclear Medicine Equipment Market Value Share Analysis, by Product 12.4. Europe Nuclear Medicine Equipment Market Forecast, by Product 12.4.1. Minimally invasive surgery 12.4.2. Open spine surgery Single-Photon Emission Computed Tomography (SPECT) 12.4.2.1. Standalone 12.4.2.2. Hybrid 12.4.3. Positron Emission Tomography (PET) 12.4.3.1. Standalone 12.4.3.2. Hybrid 12.5. Europe Nuclear Medicine Equipment Market Value Share Analysis, by Application 12.6. Europe Nuclear Medicine Equipment Market Forecast, by Application 12.6.1. Neurology 12.6.2. Oncology 12.6.3. Cardiology 12.6.4. Others 12.7. Europe Nuclear Medicine Equipment Market Value Share Analysis, by End user 12.8. Europe Nuclear Medicine Equipment Market Forecast, by End user 12.8.1. Hospitals 12.8.2. Imaging Centers 12.8.3. Academic & Research Institutes 12.9. Europe Nuclear Medicine Equipment Market Value Share Analysis, by Country 12.10. Europe Nuclear Medicine Equipment Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Nuclear Medicine Equipment Market Analysis, by Country 12.12. Germany Nuclear Medicine Equipment Market Forecast, by Product 12.12.1. Single-Photon Emission Computed Tomography (SPECT) 12.12.1.1. Standalone 12.12.1.2. Hybrid 12.12.2. Positron Emission Tomography (PET) 12.12.2.1. Standalone 12.12.2.2. Hybrid 12.13. Germany Nuclear Medicine Equipment Market Forecast, by Application 12.13.1. Neurology 12.13.2. Oncology 12.13.3. Cardiology 12.13.4. Others 12.14. Germany Nuclear Medicine Equipment Market Forecast, by End user 12.14.1. Hospitals 12.14.2. Imaging Centers 12.14.3. Academic & Research Institutes 12.15. U.K. Nuclear Medicine Equipment Market Forecast, by Product 12.15.1. Single-Photon Emission Computed Tomography (SPECT) 12.15.1.1. Standalone 12.15.1.2. Hybrid 12.15.2. Positron Emission Tomography (PET) 12.15.2.1. Standalone 12.15.2.2. Hybrid 12.16. U.K. Nuclear Medicine Equipment Market Forecast, by Application 12.16.1. Neurology 12.16.2. Oncology 12.16.3. Cardiology 12.16.4. Others 12.17. U.K. Nuclear Medicine Equipment Market Forecast, by End user 12.17.1. Hospitals 12.17.2. Imaging Centers 12.17.3. Academic & Research Institutes 12.18. France Nuclear Medicine Equipment Market Forecast, by Product 12.18.1. Single-Photon Emission Computed Tomography (SPECT) 12.18.1.1. Standalone 12.18.1.2. Hybrid 12.18.2. Positron Emission Tomography (PET) 12.18.2.1. Standalone 12.18.2.2. Hybrid 12.19. France Nuclear Medicine Equipment Market Forecast, by Application 12.19.1. Neurology 12.19.2. Oncology 12.19.3. Cardiology 12.19.4. Others 12.20. France Nuclear Medicine Equipment Market Forecast, by End user 12.20.1. Hospitals 12.20.2. Imaging Centers 12.20.3. Academic & Research Institutes 12.21. Italy Nuclear Medicine Equipment Market Forecast, by Product 12.21.1. Single-Photon Emission Computed Tomography (SPECT) 12.21.1.1. Standalone 12.21.1.2. Hybrid 12.21.2. Positron Emission Tomography (PET) 12.21.2.1. Standalone 12.21.2.2. Hybrid 12.22. Italy Nuclear Medicine Equipment Market Forecast, by Application 12.22.1. Neurology 12.22.2. Oncology 12.22.3. Cardiology 12.22.4. Others 12.23. Italy Nuclear Medicine Equipment Market Forecast, by End user 12.23.1. Hospitals 12.23.2. Imaging Centers 12.23.3. Academic & Research Institutes 12.24. Spain Nuclear Medicine Equipment Market Forecast, by Product 12.24.1. Single-Photon Emission Computed Tomography (SPECT) 12.24.1.1. Standalone 12.24.1.2. Hybrid 12.24.2. Positron Emission Tomography (PET) 12.24.2.1. Standalone 12.24.2.2. Hybrid 12.25. Spain Nuclear Medicine Equipment Market Forecast, by Application 12.25.1. Neurology 12.25.2. Oncology 12.25.3. Cardiology 12.25.4. Others 12.26. Spain Nuclear Medicine Equipment Market Forecast, by End user 12.26.1. Hospitals 12.26.2. Imaging Centers 12.26.3. Academic & Research Institutes 12.27. Rest of Europe Nuclear Medicine Equipment Market Forecast, by Product 12.27.1. Single-Photon Emission Computed Tomography (SPECT) 12.27.1.1. Standalone 12.27.1.2. Hybrid 12.27.2. Positron Emission Tomography (PET) 12.27.2.1. Standalone 12.27.2.2. Hybrid 12.28. Rest of Europe Nuclear Medicine Equipment Market Forecast, by Application 12.28.1. Neurology 12.28.2. Oncology 12.28.3. Cardiology 12.28.4. Others 12.29. Rest Of Europe Nuclear Medicine Equipment Market Forecast, by End user 12.29.1. Hospitals 12.29.2. Imaging Centers 12.29.3. Academic & Research Institutes 12.30. Europe Nuclear Medicine Equipment Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By Application 12.30.3. By End user 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Nuclear Medicine Equipment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Nuclear Medicine Equipment Market Overview 13.3. Asia Pacific Nuclear Medicine Equipment Market Value Share Analysis, by Product 13.4. Asia Pacific Nuclear Medicine Equipment Market Forecast, by Product 13.4.1. Single-Photon Emission Computed Tomography (SPECT) 13.4.1.1. Standalone 13.4.1.2. Hybrid 13.4.2. Positron Emission Tomography (PET) 13.4.2.1. Standalone 13.4.2.2. Hybrid 13.5. Asia Pacific Nuclear Medicine Equipment Market Value Share Analysis, by Application 13.6. Asia Pacific Nuclear Medicine Equipment Market Forecast, by Application 13.6.1. Neurology 13.6.2. Oncology 13.6.3. Cardiology 13.6.4. Others 13.7. Asia Pacific Nuclear Medicine Equipment Market Value Share Analysis, by End user 13.8. Asia Pacific Nuclear Medicine Equipment Market Forecast, by End user 13.8.1. Hospitals 13.8.2. Imaging Centers 13.8.3. Academic & Research Institutes 13.9. Asia Pacific Nuclear Medicine Equipment Market Value Share Analysis, by Country 13.10. Asia Pacific Nuclear Medicine Equipment Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Nuclear Medicine Equipment Market Analysis, by Country 13.12. China Nuclear Medicine Equipment Market Forecast, by Product 13.12.1. Single-Photon Emission Computed Tomography (SPECT) 13.12.1.1. Standalone 13.12.1.2. Hybrid 13.12.2. Positron Emission Tomography (PET) 13.12.2.1. Standalone 13.12.2.2. Hybrid 13.13. China Nuclear Medicine Equipment Market Forecast, by Application 13.13.1. Neurology 13.13.2. Oncology 13.13.3. Cardiology 13.13.4. Others 13.14. China Nuclear Medicine Equipment Market Forecast, by End user 13.14.1. Hospitals 13.14.2. Imaging Centers 13.14.3. Academic & Research Institutes 13.15. India Nuclear Medicine Equipment Market Forecast, by Product 13.15.1. Single-Photon Emission Computed Tomography (SPECT) 13.15.1.1. Standalone 13.15.1.2. Hybrid 13.15.2. Positron Emission Tomography (PET) 13.15.2.1. Standalone 13.15.2.2. Hybrid 13.16. India Nuclear Medicine Equipment Market Forecast, by Application 13.16.1. Neurology 13.16.2. Oncology 13.16.3. Cardiology 13.16.4. Others 13.17. India Nuclear Medicine Equipment Market Forecast, by End user 13.17.1. Hospitals 13.17.2. Imaging Centers 13.17.3. Academic & Research Institutes 13.18. Japan Nuclear Medicine Equipment Market Forecast, by Product 13.18.1. Single-Photon Emission Computed Tomography (SPECT) 13.18.1.1. Standalone 13.18.1.2. Hybrid 13.18.2. Positron Emission Tomography (PET) 13.18.2.1. Standalone 13.18.2.2. Hybrid 13.19. Japan Nuclear Medicine Equipment Market Forecast, by Application 13.19.1. Neurology 13.19.2. Oncology 13.19.3. Cardiology 13.19.4. Others 13.20. Japan Nuclear Medicine Equipment Market Forecast, by End user 13.20.1. Hospitals 13.20.2. Imaging Centers 13.20.3. Academic & Research Institutes 13.21. ASEAN Nuclear Medicine Equipment Market Forecast, by Product 13.21.1. Single-Photon Emission Computed Tomography (SPECT) 13.21.1.1. Standalone 13.21.1.2. Hybrid 13.21.2. Positron Emission Tomography (PET) 13.21.2.1. Standalone 13.21.2.2. Hybrid 13.22. ASEAN Nuclear Medicine Equipment Market Forecast, by Application 13.22.1. Neurology 13.22.2. Oncology 13.22.3. Cardiology 13.22.4. Others 13.23. ASEAN Nuclear Medicine Equipment Market Forecast, by End user 13.23.1. Hospitals 13.23.2. Imaging Centers 13.23.3. Academic & Research Institutes 13.24. Rest of Asia Pacific Nuclear Medicine Equipment Market Forecast, by Product 13.24.1. Single-Photon Emission Computed Tomography (SPECT) 13.24.1.1. Standalone 13.24.1.2. Hybrid 13.24.2. Positron Emission Tomography (PET) 13.24.2.1. Standalone 13.24.2.2. Hybrid 13.25. Rest of Asia Pacific Nuclear Medicine Equipment Market Forecast, by Application 13.25.1. Neurology 13.25.2. Oncology 13.25.3. Cardiology 13.25.4. Others 13.26. Rest of Asia Pacific Nuclear Medicine Equipment Market Forecast, by End user 13.26.1. Hospitals 13.26.2. Imaging Centers 13.26.3. Academic & Research Institutes 13.27. Asia Pacific Nuclear Medicine Equipment Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By Application 13.27.3. By End user 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Nuclear Medicine Equipment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Nuclear Medicine Equipment Market Overview 14.3. Middle East & Africa Nuclear Medicine Equipment Market Value Share Analysis, by Product 14.4. Middle East & Africa Nuclear Medicine Equipment Market Forecast, by Product 14.4.1. Single-Photon Emission Computed Tomography (SPECT) 14.4.1.1. Standalone 14.4.1.2. Hybrid 14.4.2. Positron Emission Tomography (PET) 14.4.2.1. Standalone 14.4.2.2. Hybrid 14.5. Middle East & Africa Nuclear Medicine Equipment Market Value Share Analysis, by Application 14.6. Middle East & Africa Nuclear Medicine Equipment Market Forecast, by Application 14.6.1. Neurology 14.6.2. Oncology 14.6.3. Cardiology 14.6.4. Others 14.7. Middle East & Africa Nuclear Medicine Equipment Market Value Share Analysis, by End user 14.8. Middle East & Africa Nuclear Medicine Equipment Market Forecast, by End user 14.8.1. Hospitals 14.8.2. Imaging Centers 14.8.3. Academic & Research Institutes 14.9. Middle East & Africa Nuclear Medicine Equipment Market Value Share Analysis, by Country 14.10. Middle East & Africa Nuclear Medicine Equipment Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Nuclear Medicine Equipment Market Analysis, by Country 14.12. GCC Nuclear Medicine Equipment Market Forecast, by Product 14.12.1. Single-Photon Emission Computed Tomography (SPECT) 14.12.1.1. Standalone 14.12.1.2. Hybrid 14.12.2. Positron Emission Tomography (PET) 14.12.2.1. Standalone 14.12.2.2. Hybrid 14.13. GCC Nuclear Medicine Equipment Market Forecast, by Application 14.13.1. Neurology 14.13.2. Oncology 14.13.3. Cardiology 14.13.4. Others 14.14. GCC Nuclear Medicine Equipment Market Forecast, by End user 14.14.1. Hospitals 14.14.2. Imaging Centers 14.14.3. Academic & Research Institutes 14.15. South Africa Nuclear Medicine Equipment Market Forecast, by Product 14.15.1. Single-Photon Emission Computed Tomography (SPECT) 14.15.1.1. Standalone 14.15.1.2. Hybrid 14.15.2. Positron Emission Tomography (PET) 14.15.2.1. Standalone 14.15.2.2. Hybrid 14.16. South Africa Nuclear Medicine Equipment Market Forecast, by Application 14.16.1. Neurology 14.16.2. Oncology 14.16.3. Cardiology 14.16.4. Others 14.17. South Africa Nuclear Medicine Equipment Market Forecast, by End user 14.17.1. Hospitals 14.17.2. Imaging Centers 14.17.3. Academic & Research Institutes 14.18. Rest of Middle East & Africa Nuclear Medicine Equipment Market Forecast, by Product 14.18.1. Single-Photon Emission Computed Tomography (SPECT) 14.18.1.1. Standalone 14.18.1.2. Hybrid 14.18.2. Positron Emission Tomography (PET) 14.18.2.1. Standalone 14.18.2.2. Hybrid 14.19. Rest of Middle East & Africa Nuclear Medicine Equipment Market Forecast, by Application 14.19.1. Neurology 14.19.2. Oncology 14.19.3. Cardiology 14.19.4. Others 14.20. Rest of Middle East & Africa Nuclear Medicine Equipment Market Forecast, by End user 14.20.1. Hospitals 14.20.2. Imaging Centers 14.20.3. Academic & Research Institutes 14.21. Middle East & Africa Nuclear Medicine Equipment Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Application 14.21.3. By End user 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Nuclear Medicine Equipment Market Analysis 15.1. Key Findings 15.2. South America Nuclear Medicine Equipment Market Overview 15.3. South America Nuclear Medicine Equipment Market Value Share Analysis, by Product 15.4. South America Nuclear Medicine Equipment Market Forecast, by Product 15.4.1. Single-Photon Emission Computed Tomography (SPECT) 15.4.1.1. Standalone 15.4.1.2. Hybrid 15.4.2. Positron Emission Tomography (PET) 15.4.2.1. Standalone 15.4.2.2. Hybrid 15.5. South America Nuclear Medicine Equipment Market Value Share Analysis, by Application 15.6. South America Nuclear Medicine Equipment Market Forecast, by Application 15.6.1. Neurology 15.6.2. Oncology 15.6.3. Cardiology 15.6.4. Others 15.7. South America Nuclear Medicine Equipment Market Value Share Analysis, by End user 15.8. South America Nuclear Medicine Equipment Market Forecast, by End user 15.8.1. Hospitals 15.8.2. Imaging Centers 15.8.3. Academic & Research Institutes 15.9. South America Nuclear Medicine Equipment Market Value Share Analysis, by Country 15.10. South America Nuclear Medicine Equipment Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Nuclear Medicine Equipment Market Analysis, by Country 15.12. Brazil Nuclear Medicine Equipment Market Forecast, by Product 15.12.1. Single-Photon Emission Computed Tomography (SPECT) 15.12.1.1. Standalone 15.12.1.2. Hybrid 15.12.2. Positron Emission Tomography (PET) 15.12.2.1. Standalone 15.12.2.2. Hybrid 15.13. Brazil Nuclear Medicine Equipment Market Forecast, by Application 15.13.1. Neurology 15.13.2. Oncology 15.13.3. Cardiology 15.13.4. Others 15.14. Brazil Nuclear Medicine Equipment Market Forecast, by End user 15.14.1. Hospitals 15.14.2. Imaging Centers 15.14.3. Academic & Research Institutes 15.15. Mexico Nuclear Medicine Equipment Market Forecast, by Product 15.15.1. Single-Photon Emission Computed Tomography (SPECT) 15.15.1.1. Standalone 15.15.1.2. Hybrid 15.15.2. Positron Emission Tomography (PET) 15.15.2.1. Standalone 15.15.2.2. Hybrid 15.16. Mexico Nuclear Medicine Equipment Market Forecast, by Application 15.16.1. Neurology 15.16.2. Oncology 15.16.3. Cardiology 15.16.4. Others 15.17. Mexico Nuclear Medicine Equipment Market Forecast, by End user 15.17.1. Hospitals 15.17.2. Imaging Centers 15.17.3. Academic & Research Institutes 15.18. Rest of South America Nuclear Medicine Equipment Market Forecast, by Product 15.18.1. Single-Photon Emission Computed Tomography (SPECT) 15.18.1.1. Standalone 15.18.1.2. Hybrid 15.18.2. Positron Emission Tomography (PET) 15.18.2.1. Standalone 15.18.2.2. Hybrid 15.19. Rest of South America Nuclear Medicine Equipment Market Forecast, by Application 15.19.1. Neurology 15.19.2. Oncology 15.19.3. Cardiology 15.19.4. Others 15.20. Rest of South America Nuclear Medicine Equipment Market Forecast, by End user 15.20.1. Hospitals 15.20.2. Imaging Centers 15.20.3. Academic & Research Institutes 15.21. South America Nuclear Medicine Equipment Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By Application 15.21.3. By End user 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Philips Healthcare 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Manufacturing Footprint 16.3.2. GE Healthcare 16.3.3. Cardinal Health Inc. 16.3.4. Siemens AG 16.3.5. Digirad Corporation 16.3.6. Mediso Medical Imaging Systems, Ltd. 16.3.7. Toshiba Medical Systems Corporation 16.3.8. DDD-Diagnostics A/S 16.3.9. Neusoft Medical Systems Co. Ltd. 16.3.10. Mallinckrodt plc 16.3.11. SurgicEye GmbH 16.3.12. CMR Naviscan Corporation 16.3.13. CANON MEDICAL SYSTEMS CORPORATION 16.3.14. DIGIRAD CORPORATION 16.3.15. FUJIFILM Holdings Corporation 16.3.16. Bozlu Holding 16.3.17. Compañía Mexicana de Radiología CRG 16.3.18. Bartec Technologies Ltd. 16.3.19. Biodex 16.3.20. Cyclopharm 16.3.21. Standard Imaging Inc. 17. Primary Key Insights